Bal Pharma Ltd.
BSE: 524824 | Sector: Health care |
NSE: BALPHARMA | ISIN Code: INE083D01012 |
BSE 00:00 | 19 Apr | 60.40 |
-2.00 (-3.21%) |
OPEN
63.40 |
HIGH
63.40 |
LOW
60.00 |
NSE 00:00 | 19 Apr | 60.35 |
-2.20 (-3.52%) |
OPEN
63.50 |
HIGH
63.50 |
LOW
59.25 |
OPEN | 63.40 |
PREVIOUS CLOSE | 62.40 |
VOLUME | 4740 |
52-Week high | 73.00 |
52-Week low | 33.50 |
P/E | 154.87 |
Mkt Cap.(Rs cr) | 90 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Yearly Result
Particulars (![]() |
Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
Net Sales/Income From Operations | 170.67 | 223.08 | 209.85 | 232.01 | 201.82 |
Other Income | 3.62 | 2.75 | 1.64 | 3.39 | 1.50 |
Total Income | 174.29 | 225.83 | 211.49 | 235.40 | 203.32 |
Total Expenditure | 163.92 | 202.77 | 187.06 | 211.90 | 184.69 |
Operating Profit | 10.37 | 23.05 | 24.43 | 23.51 | 18.64 |
Interest | 12.42 | 12.53 | 9.24 | 8.46 | 6.48 |
Gross Profit | -2.05 | 10.53 | 15.18 | 15.05 | 12.16 |
Depreciation | 7.03 | 6.12 | 6.73 | 6.46 | 6.97 |
PBT | -9.07 | 4.41 | 8.46 | 8.59 | 5.19 |
Tax | -0.17 | -2.35 | 2.52 | 3.28 | 2.38 |
Net Profit/(Loss) | -8.90 | 6.76 | 5.94 | 5.31 | 2.81 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | -8.90 | 6.76 | 5.94 | 5.31 | 2.81 |
Equity Share Capital | 14.17 | 14.17 | 14.17 | 14.17 | 12.87 |
Reserves Excluding Revaluation Reserves | 51.15 | 62.69 | 58.06 | 50.71 | 0.00 |
EPS | |||||
Basic EPS | -6.28 | 4.77 | 4.19 | 3.50 | 2.18 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0.66 | 0.66 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 51.17 | 51.17 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0.63 | 0.63 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 44.35 | 48.83 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices